Unknown

Dataset Information

0

Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational research.


ABSTRACT: Although re-sequencing of gene panels and mRNA expression profiling are now firmly established in clinical laboratories, in-depth proteome analysis has remained a niche technology, better suited for studying model systems rather than challenging materials such as clinical trial samples. To address this limitation, we have developed a novel and optimized platform called SP3-Clinical Tissue Proteomics (SP3-CTP) for in-depth proteome profiling of practical quantities of tumour tissues, including formalin fixed and paraffin embedded (FFPE). Using single 10??m scrolls of clinical tumour blocks, we performed in-depth quantitative analyses of individual sections from ovarian tumours covering the high-grade serous, clear cell, and endometrioid histotypes. This examination enabled the generation of a novel high-resolution proteome map of ovarian cancer histotypes from clinical tissues. Comparison of the obtained proteome data with large-scale genome and transcriptome analyses validated the observed proteome biology for previously validated hallmarks of this disease, and also identified novel protein features. A tissue microarray analysis validated cystathionine gamma-lyase (CTH) as a novel clear cell carcinoma feature with potential clinical relevance. In addition to providing a milestone in the understanding of ovarian cancer biology, these results show that in-depth proteomic analysis of clinically annotated FFPE materials can be effectively used as a biomarker discovery tool and perhaps ultimately as a diagnostic approach.

SUBMITTER: Hughes CS 

PROVIDER: S-EPMC5054533 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational research.

Hughes Christopher S CS   McConechy Melissa K MK   Cochrane Dawn R DR   Nazeran Tayyebeh T   Karnezis Anthony N AN   Huntsman David G DG   Morin Gregg B GB  

Scientific reports 20161007


Although re-sequencing of gene panels and mRNA expression profiling are now firmly established in clinical laboratories, in-depth proteome analysis has remained a niche technology, better suited for studying model systems rather than challenging materials such as clinical trial samples. To address this limitation, we have developed a novel and optimized platform called SP3-Clinical Tissue Proteomics (SP3-CTP) for in-depth proteome profiling of practical quantities of tumour tissues, including fo  ...[more]

Similar Datasets

| S-EPMC9326557 | biostudies-literature
| S-EPMC7236785 | biostudies-literature
| S-EPMC8358594 | biostudies-literature
| S-EPMC2893624 | biostudies-literature
| S-EPMC1618650 | biostudies-literature
| S-EPMC5608257 | biostudies-literature
| S-EPMC8292114 | biostudies-literature
| S-EPMC3065290 | biostudies-literature
| S-EPMC3284398 | biostudies-literature
| S-EPMC9406261 | biostudies-literature